Severe hypertension following ephedrine administration in a patient receiving entacapone.
Renfrew
C
C
Dickson
R
R
Schwab
C
C
D000368:Aged; D018686:Anesthetics, Intravenous; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000009:adverse effects*; D002396:Catechols / Q000009:adverse effects*; D004347:Drug Interactions; D004809:Ephedrine / Q000009:adverse effects*; D005260:Female; D005283:Fentanyl; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000139:chemically induced* / Q000188:drug therapy; D009570:Nitriles; D015742:Propofol; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
D018686:Anesthetics, Intravenous; D000959:Antihypertensive Agents; D000978:Antiparkinson Agents; D002396:Catechols; D009570:Nitriles; D014662:Vasoconstrictor Agents; D006830:Hydralazine; C071192:entacapone; D004809:Ephedrine; D005283:Fentanyl; D015742:Propofol